Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance

MLA

Yu, T., et al. “Cytoplasmic GPER Translocation in Cancer-Associated Fibroblasts Mediates CAMP/PKA/CREB/Glycolytic Axis to Confer Tumor Cells with Multidrug Resistance.” Oncogene, vol. 36, no. 15, Apr. 2017, pp. 2131–45. EBSCOhost, https://doi.org/10.1038/onc.2016.370.

APA

Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X., Guo, L., Zhu, Q., Luo, H., Du, Y., Wen, S., Xu, L., Yin, J., Tu, G., & Liu, M. (2017). Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance. Oncogene, 36(15), 2131–2145. https://doi.org/10.1038/onc.2016.370

Chicago

Yu, T, G Yang, Y Hou, X Tang, C Wu, X-a Wu, L Guo, et al. 2017. “Cytoplasmic GPER Translocation in Cancer-Associated Fibroblasts Mediates CAMP/PKA/CREB/Glycolytic Axis to Confer Tumor Cells with Multidrug Resistance.” Oncogene 36 (15): 2131–45. doi:10.1038/onc.2016.370.